Delivered 6% Labs and 9% TRIAGE growth, as reported, and 240 bps of adjusted EBITDA margin expansion in FY25 ? ? Continued growth and margin expansion expected in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results